Vaxonyx AI

AI Platforms for Biomedical Discovery

Vaxonyx develops intelligent bioinformatics platforms that help researchers move from complex biological data to meaningful, actionable insights. Our platforms are designed to make advanced analysis more accessible, efficient, and reproducible.

✓ Built for researchers ✓ Secure cloud workflows ✓ No server setup required

AI Platforms

Available and upcoming scientific platforms

Begin with our available Bulk RNA-Seq Analysis platform. Additional Vaxonyx AI platforms for immunogenomics, therapeutic discovery, and precision medicine are currently under development.

Available Now

Bulk RNA-Seq Analysis

AI-enhanced end-to-end transcriptomic analysis

Upload raw sequencing data and move through automated processing, quality assessment, differential expression, pathway discovery, biological interpretation, and publication-ready visualization.

  • FASTQ file upload
  • Quality assessment
  • Alignment and normalization
  • Differential expression
  • AI-assisted outlier detection
  • Pathway analysis
  • Gene and TF analysis
  • Publication-ready plots
Open Bulk RNA-Seq Platform
Under Development

Neoantigen Discovery

Personalized immunogenomic discovery workflows

An AI-assisted platform for identifying, prioritizing, and interpreting candidate neoantigens for cancer immunology, personalized vaccine research, and translational studies.

Under Development
Under Development

HLA Typing

AI-assisted immunogenomic characterization

A planned platform supporting HLA typing and interpretation for immunogenomics, transplant research, neoantigen analysis, vaccine development, and personalized medicine.

Under Development
Under Development

Variant Calling

Genomic variant identification and prioritization

A planned AI-assisted workflow for genomic variant calling, annotation, prioritization, interpretation, and structured reporting for research and translational applications.

Under Development

Looking for our therapeutic and vaccine pipelines?

Vaxonyx AI Platforms are focused on computational and bioinformatics products. Our vaccine, therapeutic, delivery, and translational development pipelines remain under the Innovation section.

Explore Innovation